Skip to main content
. 2018 May 30;16(2):529–536. doi: 10.3892/etm.2018.6235

Figure 5.

Figure 5.

Effect of anti-TNF-α treatment on HCC tumor cell apoptosis in vitro and in vivo. (A) Level of cleaved caspase-3 in HepG2 and Hep3B cells following infliximab treatment in the presence of effector cells or complement. (B) Cleaved caspase-3 expression following infliximab treatment in HCC xenograft mouse model tissues. Magnification, ×200. Scale bar, 50 µm. *P<0.05, ***P<0.001 vs. mock. HCC, hepatocellular carcinoma; TNF-α, tumor necrosis factor-α.